ELA vs VRTX · P/E 21, rev $155.2M vs P/E 30, rev $3.33B
Envela Corp (ELA) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Envela Corp (ELA) is a luxury goods company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ELA revenue for 2026-06-30 was $155.2M. Net income was $13.0M. Revenue was up 57.7% from 2026-03-31 to 2026-06-30. ELA currently screens at market cap $158.1M and trailing P/E 21.0.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ELA currently screens at market cap $158.1M and trailing P/E 21.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ELA and VRTX stock pages for the full models.
Not investment advice.